MESOBLAST LIMITED

2.52%

$2.32

Market Cap $2.969B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

MSB Biotech

MSB - a new dawn

42 43 44

04:57

2.6K

1.1M

04:57

Last post Moreforme

2.6K

1.1M

MSB

MSB Video channel'

3 4 5

20/08/25

260

115K

20/08/25

Last post csrwin

260

115K

MSB

Cell Therapy News/Articles

331 332 333

20/08/25

19K

8.5M

20/08/25

Last post nippy

19K

8.5M

MSB

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

6 7 8

20/08/25

450

201K

20/08/25

Last post stockman49

450

201K

MSB

Mesoblast 2025: The year of acting like a publicly listed company

24 25 26

20/08/25

1.5K

573K

20/08/25

Last post dolcevita

1.5K

573K

MSB

MESO Nasdaq update

115 116 117

20/08/25

7.0K

3.6M

20/08/25

Last post rakeshnirzari1

7.0K

3.6M

MSB

NASDAQ Meso daily flow charts

4 5 6

20/08/25

316

134K

20/08/25

Last post maudeward

316

134K

MSB

CLBP Trial 2024

19/08/25

54K

19/08/25

Last post csrwin

54K

See All Discussions

Timeline

Becoming a substantial holder
29 Jul 19:26	Share

Ceasing to be a substantial holder
25 Jul 18:50	Share

Ceasing to be a substantial holder
25 Jul 08:17	Share

Becoming a substantial holder
23 Jul 08:14	Share

Ceasing to be a substantial holder
21 Jul 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
18 Jul 09:58	Share

Becoming a substantial holder
18 Jul 08:20	Share

Notification of cessation of securities - MSB
14 Jul 18:23	Share

Notification regarding unquoted securities - MSB
14 Jul 18:19	Share

Application for quotation of securities - MSB
14 Jul 18:14	Share

Notification regarding unquoted securities - MSB
14 Jul 18:08	Share

Ceasing to be a substantial holder
08 Jul 18:46	Share

Becoming a substantial holder
07 Jul 08:20	Share

Mesoblast and FDA Align on Key Items for Revascor BLA
01 Jul 09:49	Share

Ceasing to be a substantial holder
26 Jun 08:21	Share

Ceasing to be a substantial holder
18 Jun 08:19	Share

Becoming a substantial holder
17 Jun 08:23	Share

Ceasing to be a substantial holder
16 Jun 08:19	Share

Mesoblast Maintains Momentum with FDA
12 Jun 10:14	Share

Becoming a substantial holder
06 Jun 08:21	Share

Becoming a substantial holder
05 Jun 08:18	Share

Becoming a substantial holder
03 Jun 15:59	Share

Ceasing to be a substantial holder
03 Jun 08:21	Share

FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
15 May 10:01	Share

Becoming a substantial holder
14 May 08:18	Share

Ceasing to be a substantial holder
09 May 08:24	Share

Becoming a substantial holder
08 May 08:20	Share

Ceasing to be a substantial holder
07 May 15:26	Share

Becoming a substantial holder
02 May 14:07	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:13	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.32		Change -0.060(2.52%)		Mkt cap ! $2.969B

Open	High	Low	Value	Volume
$2.34	$2.40	$2.30	$7.243M	3.111M

Buyers (Bids)

No.	Vol.	Price($)
1	8	$2.31

Sellers (Offers)

Price($)	Vol.	No.
$2.32	17482	2

View Market Depth

No.	Vol.	Price($)
1	8	2.310
3	33917	2.300
9	69850	2.290
10	37461	2.280
2	7000	2.270

Price($)	Vol.	No.
2.320	17482	2
2.330	11000	2
2.340	29896	4
2.350	67873	4
2.360	20000	2

Last trade - 16.10pm 20/08/2025 (20 minute delay)

MSB (ASX) Chart

MESOBLAST LIMITED

Latest Threads

Redcastle Resources (ASX:RC1): Strategic JV to Expedite Gold Production & Major Tenement Expansion in Eastern Goldfields

Timeline

Featured News

Latest Videos

Mesoblast (ASX:MSB) flags strengthened heart function in latest trial results

28 Feb 2023 10:07 (AEDT)

Latest Articles

The market shrugged at Mesoblast's latest FDA win. Is it just another Droneshield?

Mesoblast (ASX:MSB) has revealed the US FDA has given its flagship drug a 7 year exclusivity period, blocking...

Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab

Mesoblast (ASX:MSB) has seen shares fall just shy of -3% heading into lunchtime trades despite apparent tariff relief.

Mesoblast kicks off treatment for first 3 kids with graft-host disease. So why are shares down?

otCopper favourite Mesoblast (ASX:MSB) has announced it's begun treating the first 3 children with skin graft-versus-host disease in the US, at the same time the company received medicare (US) and medicaid coverage.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News